554
Views
36
CrossRef citations to date
0
Altmetric
Editorial

Development of synthetic biodegradable microparticulate vaccines: a roller coaster story

, &
Pages 471-474 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kyprianos Michaelides, Maruthi Prasanna, Raj Badhan, Afzal-Ur-Rahman Mohammed, Adam Walters, M. Keith Howard, Pawan Dulal & Ali Al-Khattawi. (2023) Single administration vaccines: delivery challenges, in vivo performance, and translational considerations. Expert Review of Vaccines 22:1, pages 579-595.
Read now
Dylan A. Hendy, Alex Haven, Eric M. Bachelder & Kristy M. Ainslie. (2023) Preclinical developments in the delivery of protein antigens for vaccination. Expert Opinion on Drug Delivery 20:3, pages 367-384.
Read now
Francesca Ungaro, Claudia Conte, Fabiana Quaglia, Maria Lina Tornesello, Franco M Buonaguro & Luigi Buonaguro. (2013) VLPs and particle strategies for cancer vaccines. Expert Review of Vaccines 12:10, pages 1173-1193.
Read now
Benjamin G. Keselowsky, Chang Qing Xia & Michael Clare-Salzler. (2011) Multifunctional dendritic cell-targeting polymeric microparticles. Human Vaccines 7:1, pages 37-44.
Read now

Articles from other publishers (32)

Yongxin Zhang, Jiajing Chen, Linqi Shi & Feihe Ma. (2023) Polymeric nanoparticle-based nanovaccines for cancer immunotherapy. Materials Horizons 10:2, pages 361-392.
Crossref
Elizabeth G. Graham-Gurysh, Brandon W. Carpenter, Wolfgang A. Beck, Devika M. Varma, Benjamin G. Vincent, Eric M. Bachelder & Kristy M. Ainslie. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies 359 408 .
Jairam Meena, Dinesh Giri Goswami, Chakkumkal Anish & Amulya Kumar Panda. (2021) Cellular uptake of polylactide particles induces size dependent cytoskeletal remodeling in antigen presenting cells. Biomaterials Science 9:23, pages 7962-7976.
Crossref
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder & Kristy M. Ainslie. (2021) Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases. Advanced NanoBiomed Research 1:3.
Crossref
Sudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, Mathew Pham, Traci Legere, Zarpheen Jinnah SherYevgeny Kovalenkov, Sanjeev Gumber, Jessica Y. Huang, Raphael Gottardo, William FulpAlicia Sato, Sheetal Sawant, Sherry Stanfield-Oakley, Nicole Yates, Celia LaBranche, S. Munir Alam, Georgia TomarasGuido FerrariDavid Montefiori, Jens Wrammert, Francois Villinger, Mark Tomai, John VasilakosChristopher B. Fox, Steven G. ReedBarton F. HaynesShane Crotty, Rafi Ahmed & Bali Pulendran. (2020) 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates. Science Immunology 5:48.
Crossref
Mona Yazdani, Mahmoud Reza Jaafari, Javad Verdi, Behrang Alani, Mahdi Noureddini & Ali Badiee. (2020) Ex vivo- generated dendritic cell-based vaccines in melanoma: the role of nanoparticulate delivery systems . Immunotherapy 12:5, pages 333-349.
Crossref
Rebeca T. Steipel, Matthew D. Gallovic, Cole J. Batty, Eric M. Bachelder & Kristy M. Ainslie. (2019) Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo. Materials Science and Engineering: C 105, pages 110070.
Crossref
May Tun Saung, Xiyu Ke, Gregory P. Howard, Lei Zheng & Hai-Quan Mao. (2019) Particulate carrier systems as adjuvants for cancer vaccines. Biomaterials Science 7:12, pages 4873-4887.
Crossref
Zehra AKINCI & Hakan KALENDER. (2019) Enfeksiyöz Nekrotik Hepatitis Aşısının Üretiminde Poli (D, L-Laktik-Ko-Glikolik Asit) (PLGA) Biyopolimerinin Adjuvant Etkisinin Araştırılması. Etlik Veteriner Mikrobiyoloji Dergisi 30:1, pages 70-77.
Crossref
Michael A. Collier, Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson, Monica M. Johnson, Andrew N. Macintyre, Gregory D. Sempowski, Eric M. Bachelder, Jenny P.-Y. Ting & Kristy M. Ainslie. (2018) Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists. Molecular Pharmaceutics 15:11, pages 4933-4946.
Crossref
Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson, Michael A. Collier, Rebekah Watkins-Schulz, Ning Cheng, Clément N. David, Charles E. McGee, Gregory D. Sempowski, Ivo Shterev, Karen McKinnon, Eric M. Bachelder, Kristy M. Ainslie & Jenny P.-Y. Ting. (2018) A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. Journal of Controlled Release 270, pages 1-13.
Crossref
Matthew D. Gallovic, Kevin L. Schully, Matthew G. Bell, Margaret A. Elberson, John R. Palmer, Christian A. Darko, Eric M. Bachelder, Barbara E. Wyslouzil, Andrea M. Keane-Myers & Kristy M. Ainslie. (2016) Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure . Advanced Healthcare Materials 5:20, pages 2617-2627.
Crossref
Thomas Schuster, Martin Nussbaumer, Patric Baumann, Nico Bruns, Wolfgang Meier & Anja Car. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery 181 201 .
Dharmendra Raghuwanshi, Vivek Mishra, Mavanur R. Suresh & Kamaljit Kaur. (2012) A simple approach for enhanced immune response using engineered dendritic cell targeted nanoparticles. Vaccine 30:50, pages 7292-7299.
Crossref
Amulya K. Panda. (2012) Nanotechnology in Vaccine Development. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 82:S1, pages 13-27.
Crossref
Shashi Prasad, Virginia Cody, Jennifer K. Saucier-Sawyer, Tarek R. Fadel, Richard L. Edelson, Martin A. Birchall & Douglas J. Hanlon. (2012) Optimization of Stability, Encapsulation, Release, and Cross-Priming of Tumor Antigen-Containing PLGA Nanoparticles. Pharmaceutical Research 29:9, pages 2565-2577.
Crossref
Nick X. Wang, Douglas A. Bazdar, Scott F. Sieg & Horst A. von Recum. (2012) Microparticle delivery of Interleukin-7 to boost T-cell proliferation and survival. Biotechnology and Bioengineering 109:7, pages 1835-1843.
Crossref
Sean M. Geary, Caitlin D. Lemke, Yogita Krishnamachari & Aliasger K. Salem. 2012. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 391 421 .
Camilla Foged, Jon Hansen & Else Marie Agger. (2012) License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems. European Journal of Pharmaceutical Sciences 45:4, pages 482-491.
Crossref
Deepa Mohanan, Bruno Gander, Thomas M. Kündig & Pål Johansen. (2012) Encapsulation of antigen in poly(d,l-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. European Journal of Pharmaceutics and Biopharmaceutics 80:2, pages 274-281.
Crossref
Camilla Foged. (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Therapeutic Delivery 2:8, pages 1057-1077.
Crossref
Marie-Luce De Temmerman, Joanna Rejman, Jo Demeester, Darrell J. Irvine, Bruno Gander & Stefaan C. De Smedt. (2011) Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discovery Today 16:13-14, pages 569-582.
Crossref
Abhinav P. Acharya & Niren Murthy. (2011) Immunity without harm. Nature Materials 10:3, pages 166-168.
Crossref
Shashi Prasad, Virginia Cody, Jennifer K. Saucier-Sawyer, W. Mark Saltzman, Clarence T. Sasaki, Richard L. Edelson, Martin A. Birchall & Douglas J. Hanlon. (2011) Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell–based antitumor immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 7:1, pages 1-10.
Crossref
Yogita Krishnamachari, Sean M. Geary, Caitlin D. Lemke & Aliasger K. Salem. (2010) Nanoparticle Delivery Systems in Cancer Vaccines. Pharmaceutical Research 28:2, pages 215-236.
Crossref
Liesbeth J. De Cock, Stefaan De Koker, Bruno G. De Geest, Johan Grooten, Chris Vervaet, Jean Paul Remon, Gleb B. Sukhorukov & Maria N. Antipina. (2010) Polymeric Multilayer Capsules in Drug Delivery. Angewandte Chemie International Edition 49:39, pages 6954-6973.
Crossref
Liesbeth J. De Cock, Stefaan De Koker, Bruno G. De Geest, Johan Grooten, Chris Vervaet, Jean Paul Remon, Gleb B. Sukhorukov & Maria N. Antipina. (2010) Wirkstoffverabreichung mithilfe polymerer Mehrschichtkapseln. Angewandte Chemie 122:39, pages 7108-7127.
Crossref
Stefaan De Koker, Bruno G. De Geest, Satwinder K. Singh, Riet De Rycke, Thomas Naessens, Yvette Van Kooyk, Jo Demeester, Stefaan C. De Smedt & Johan Grooten. (2009) Polyelectrolyte Microcapsules as Antigen Delivery Vehicles To Dendritic Cells: Uptake, Processing, and Cross‐Presentation of Encapsulated Antigens. Angewandte Chemie International Edition 48:45, pages 8485-8489.
Crossref
Stefaan De Koker, Bruno G. De Geest, Satwinder K. Singh, Riet De Rycke, Thomas Naessens, Yvette Van Kooyk, Jo Demeester, Stefaan C. De Smedt & Johan Grooten. (2009) Polyelectrolyte Microcapsules as Antigen Delivery Vehicles To Dendritic Cells: Uptake, Processing, and Cross‐Presentation of Encapsulated Antigens. Angewandte Chemie 121:45, pages 8637-8641.
Crossref
Myrra G. Carstens. (2009) Opportunities and challenges in vaccine delivery. European Journal of Pharmaceutical Sciences 36:4-5, pages 605-608.
Crossref
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology 189 242 .
Julia M. Martínez Gómez, Noémi Csaba, Stefan Fischer, Anke Sichelstiel, Thomas M. Kündig, Bruno Gander & Pål Johansen. (2008) Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. Journal of Controlled Release 130:2, pages 161-167.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.